MX2023010948A - Compuestos antibacterianos. - Google Patents
Compuestos antibacterianos.Info
- Publication number
- MX2023010948A MX2023010948A MX2023010948A MX2023010948A MX2023010948A MX 2023010948 A MX2023010948 A MX 2023010948A MX 2023010948 A MX2023010948 A MX 2023010948A MX 2023010948 A MX2023010948 A MX 2023010948A MX 2023010948 A MX2023010948 A MX 2023010948A
- Authority
- MX
- Mexico
- Prior art keywords
- antibacterial compounds
- compounds
- antibacterial
- tuberculosis
- medicaments
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invención se relaciona con los siguientes Compuestos (I), en donde los enteros son como se definen en la descripción, y donde los compuestos pueden ser útiles como medicamentos, por ejemplo para su uso en el tratamiento de la tuberculosis. (ver formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21163040 | 2021-03-17 | ||
PCT/EP2022/056772 WO2022194905A1 (en) | 2021-03-17 | 2022-03-16 | Antibacterial compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023010948A true MX2023010948A (es) | 2023-11-28 |
Family
ID=74947092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023010948A MX2023010948A (es) | 2021-03-17 | 2022-03-16 | Compuestos antibacterianos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20240199651A1 (es) |
EP (1) | EP4308238A1 (es) |
JP (1) | JP2024509997A (es) |
KR (1) | KR20230158046A (es) |
CN (1) | CN117580843A (es) |
AU (1) | AU2022240967A1 (es) |
BR (1) | BR112023018655A2 (es) |
CA (1) | CA3211592A1 (es) |
MX (1) | MX2023010948A (es) |
WO (1) | WO2022194905A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202325274A (zh) * | 2021-10-28 | 2023-07-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | 抗菌化合物 |
WO2024089170A1 (en) * | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1527050T1 (sl) | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji |
SG184073A1 (en) | 2010-03-18 | 2012-10-30 | Pasteur Institut Korea | Anti-infective compounds |
BR112014004560A2 (pt) | 2011-09-01 | 2017-04-04 | Irm Llc | compostos e composições como inibidores de c-kit quinase |
US9199981B2 (en) | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
RU2696278C2 (ru) | 2012-07-18 | 2019-08-01 | Юниверсити Оф Нотр Дам Дю Лак | 5,5-гетероароматические противоинфекционные соединения |
WO2015014993A2 (en) | 2013-08-02 | 2015-02-05 | Institut Pasteur Korea | Anti-infective compounds |
LT3316969T (lt) | 2015-07-02 | 2022-03-25 | Janssen Sciences Ireland Unlimited Company | Antibakteriniai junginiai |
KR20190017948A (ko) | 2016-06-16 | 2019-02-20 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 항균제로서의 헤테로고리 화합물 |
MA45375A (fr) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Co | Composés hétérocycliques utilisés en tant qu'agents antibacteriens |
-
2022
- 2022-03-16 JP JP2023556982A patent/JP2024509997A/ja active Pending
- 2022-03-16 MX MX2023010948A patent/MX2023010948A/es unknown
- 2022-03-16 CN CN202280035463.4A patent/CN117580843A/zh active Pending
- 2022-03-16 CA CA3211592A patent/CA3211592A1/en active Pending
- 2022-03-16 US US18/550,342 patent/US20240199651A1/en active Pending
- 2022-03-16 EP EP22715592.6A patent/EP4308238A1/en active Pending
- 2022-03-16 AU AU2022240967A patent/AU2022240967A1/en active Pending
- 2022-03-16 WO PCT/EP2022/056772 patent/WO2022194905A1/en active Application Filing
- 2022-03-16 KR KR1020237035123A patent/KR20230158046A/ko unknown
- 2022-03-16 BR BR112023018655A patent/BR112023018655A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
CA3211592A1 (en) | 2022-09-22 |
WO2022194905A1 (en) | 2022-09-22 |
AU2022240967A1 (en) | 2023-11-02 |
BR112023018655A2 (pt) | 2023-12-12 |
JP2024509997A (ja) | 2024-03-05 |
US20240199651A1 (en) | 2024-06-20 |
EP4308238A1 (en) | 2024-01-24 |
CN117580843A (zh) | 2024-02-20 |
KR20230158046A (ko) | 2023-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502298B1 (en) | Antibacterial compounds | |
MX2022003037A (es) | Compuestos antibacterianos. | |
MX2018015656A (es) | Compuestos heterociclicos como antibacterianos. | |
MX2018015657A (es) | Compuestos heterociclico como antibacterianos. | |
MX2023010941A (es) | Compuestos antibacterianos. | |
MX2023010948A (es) | Compuestos antibacterianos. | |
MX2019011530A (es) | Saxitoxinas 11,13-modificadas para el tratamiento del dolor. | |
EP2493464A4 (en) | METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS | |
MX2022009164A (es) | N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos. | |
MX2022001004A (es) | Inhibidores de enzimas. | |
MX2020011817A (es) | Metodos para tratar el linfoma. | |
MX2017009450A (es) | Composicion yodofora novedosa y metodos de uso. | |
ZA202201364B (en) | Deuterated compounds for use in the treatment of cancer | |
AU2020231934A8 (en) | Compounds useful in HIV therapy | |
MX2022000811A (es) | Inhibidores de enzimas. | |
WO2019040105A3 (en) | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES | |
MX2022003816A (es) | Compuestos antibacterianos. | |
MX2022003814A (es) | Compuestos antibacterianos de 4-quinolinona. | |
MX2022010093A (es) | Tafoxiparina para el tratamiento de la preeclampsia. | |
MX2023010947A (es) | Compuestos antibacterianos. | |
EP4344749A3 (en) | Protease formulation for treatment of microbial infections | |
MX2019000006A (es) | Composiciones para el tratamiento de estrias y ulceras de origen isquemico. | |
WO2019055748A8 (en) | Hydrogen-containing composition | |
PH12015501428A1 (en) | Antibacterial compounds | |
MX2021004819A (es) | Composiciones y metodos para tratar lesiones cerebrales. |